Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-07-17

FDA Approved: NEFAZODONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for NEFAZODONE HYDROCHLORIDE from Teva Pharmaceuticals USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NEFAZODONE HYDROCHLORIDE (nefazodone hydrochloride)

Snippet

SUPPL AP for NEFAZODONE HYDROCHLORIDE (NEFAZODONE HYDROCHLORIDE)